GoodRx withdraws $662 million term loan B from market

By Sara Rosenberg

New York, Feb. 5 – GoodRx pulled its $662 million seven-year term loan B (B1) from the primary market, according to a market source.

Talk on the term loan was SOFR plus 300 basis points to 325 bps with a 0% floor and an original issue discount of 99.5.

The term loan was also talked with 101 soft call protection for six months, no CSA and amortization of 1% per annum.

Goldman Sachs Bank USA was the left lead arranger on the deal.

Proceeds were going to be used to refinance an existing first-lien term loan due October 2025.

Silver Lake Partners and Francisco Partners are the sponsors.

GoodRx is a Santa Monica, Calif.-based consumer-focused digital health care platform.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.